Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Royaume-Uni (3)
Musculoskeletal/Multiple Sclerosis (MS) (1)
Pharmaceutical, Biotech, Medical Device Company (0)
Payers (usually governmental or public bodies, reimbursement)
Continuity and sustainability
Health Technology Assessment (HTA) activities